Karpus Management Slashes Three SPAC Positions Including 87% Cut to YHNA

The Quick Take

• Karpus Management cut YHN Acquisition I (YHNA) stake by 87.25%, effectively exiting the position
• SPACSphere Acquisition Corp (SSAC) and RF Acquisition Corp II (RFAI) also trimmed in same period
• Simultaneous reductions across three SPACs signal systematic de-risking of blank-check exposure
• Continued institutional exits reflect persistent fatigue with SPAC vehicles yet to announce business combinations

Karpus Management disclosed significant simultaneous reductions across three separate SPAC positions in the same filing period. The most dramatic move was an 87.25% trim of its stake in YHN Acquisition I Ltd, a near-complete exit signaling deep skepticism about that vehicle's prospects. Alongside this, the firm also reduced positions in SPACSphere Acquisition Corp and RF Acquisition Corp II by varying degrees. The breadth of the trimming across three distinct SPACs simultaneously points to a deliberate portfolio repositioning rather than opportunistic selling on any single deal development.

The SPAC market has faced persistent headwinds since the 2021 peak, with many blank-check vehicles trading at or below NAV as deal timelines extend and investor patience exhausts. Karpus's moves are consistent with a broader institutional trend of exiting SPAC positions ahead of redemption deadlines to redeploy capital into higher-conviction ideas. For remaining SPAC shareholders, concentrated institutional exits of this magnitude can pressure share prices toward the redemption floor, particularly if the selling triggers calculations showing insufficient trust value remaining to complete the planned acquisition.

Market watchers tracking the SPAC ecosystem will note that Karpus continues to hold a diversified base portfolio including BLV, VOO, and VB ETFs alongside its alternatives exposure, suggesting the manager remains constructive on broad equity markets while specifically reducing structured-vehicle risk. For SPAC sponsors still searching for acquisition targets, losing a multi-position institutional holder like Karpus reduces the stable base of patient capital available. This makes announced deals progressively harder to complete without significant dilution from warrant exercises or earnout adjustments negotiated under increasing shareholder pressure.

Synthesized from 3 sources.